A nanoparticle platform for multiple immune tolerance therapies
Time: 3:00 pm
day: Day One
Details:
- Broad therapeutic potential of our proprietary Topas Particle Conjugates delivering peptide antigens to special liver cells
- Diverse mechanism-of-action through different immune pathways to rebalance the immune system
- Pemphigus vulgaris and Celiac disease as strong clinical models
